En esta página
01IMDX precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
IMDX Insight Molecular Diagnostics Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 10, 2026
$3,44
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,42mínimo 52 semanas
$8,51máximo 52 semanas
Capitalización Bursátil (MRQ)
$112M
P/E (TTM)
-2.3
BPA (TTM)
$-1.52
Ingresos (TTM)
$2M
tus insignias
Rango 52S
$2–$9
Calificación del Analista
BUY
Precio Objetivo
$8
P/E
-2.3
ROE
488.7%
Margen de Beneficio Neto
-2955.6%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
IMDX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$3.44
Capitalización Bursátil (MRQ)
$112M
P/E (TTM)
-2.3
BPA (TTM)
$-1.52
Ingresos (TTM)
$2M
ROE (TTM)
488.7%
Rango 52S
$2–$9
IMDX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 25 de julio de 2023 | 1-for-20 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$4M2020-12-31 → 2025-12-31
BPA$-1.652022-12-31 → 2025-12-31
Flujo de caja libre$-25M2016-12-31 → 2025-12-31
Margen neto-2955.6%2016-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | IMDX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -2.3promedio 5A ≈-1.6 | ≈-1.6 | · | · | |
| P/S (TTM) | 67.2promedio 5A ≈29.6 | ≈29.6 | 43.3 | Sobrevalorado | |
| P/C (MRQ) | -5.3promedio 5A ≈-3.1 | ≈-3.1 | · | · | |
| Precio / FCF (TTM) | -3.6promedio 5A ≈-3.8 | ≈-3.8 | · | · | |
| Precio / Flujo de Caja (TTM) | -4.2promedio 5A ≈-4.2 | ≈-4.2 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | IMDX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Bruto (TTM) | 47.6%promedio 5A ≈41.2% | ≈41.2% | · | · | |
| Margen Operativo (TTM) | -3011.9%promedio 5A ≈-2059.4% | ≈-2059.4% | -583.5% | Débil | |
| Margen EBITDA (TTM) | -2865.6%promedio 5A ≈-2013.7% | ≈-2013.7% | -583.5% | Débil | |
| Margen de Beneficio Neto (TTM) | -2955.6%promedio 5A ≈-2104.0% | ≈-2104.0% | -597.4% | Débil | |
| ROA (TTM) | -123.5%promedio 5A ≈-102.4% | ≈-102.4% | -54.3% | Débil | |
| ROE (TTM) | 488.7%promedio 5A ≈1655.5% | ≈1655.5% | -61.8% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | IMDX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 2.0promedio 5A ≈1.5 | ≈1.5 | 7.7 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 1.1promedio 5A ≈1.3 | ≈1.3 | 7.5 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | IMDX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 115.6%promedio 5A ≈44.4% | ≈44.4% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 61.8%promedio 5A ≈21.3% | ≈21.3% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 27.2% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | IMDX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.1promedio 5A ≈0.1 | ≈0.1 | 0.1 | De primer nivel | |
| Inventory Turnover (Rotación de Inventario) | 4.1 | · | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 3.0promedio 5A ≈2.5 | ≈2.5 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$73.7K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-86.3%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-0.31 | $-0.25 | -24.4% |
| 31 de marzo de 2026 | May 13, 2026 | $-0.12 | $-0.27 | 55.0% |
| 31 de diciembre de 2025 | $-0.72 | $-0.24 | -197.5% | |
| 30 de septiembre de 2025 | $-0.34 | $-0.21 | -59.0% | |
| 30 de junio de 2025 | $-0.30 | $-0.23 | -27.9% | |
| 31 de marzo de 2025 | $-0.26 | $-0.24 | -7.8% | |
| 31 de diciembre de 2024 | $-1.93 | $-0.44 | -342.8% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $2M | $2M | $958.0K | $2M | $1M | · | · | · | · | $0 | |
| Cost of Revenue | $2M | $1M | $1M | $880.0K | $697.0K | $2M | · | · | · | · | · | |
| Gross Profit | $2M | $740.0K | $413.0K | $-18.0K | $1M | $-639.0K | · | · | · | · | · | |
| R&D Expense | $16M | $10M | $9M | $7M | $5M | $10M | $7M | $7M | $7M | $6M | $5M | |
| SG&A Expense | $11M | $10M | $11M | $22M | $22M | $17M | $13M | $7M | $9M | $4M | $4M | |
| Operating Expenses | $53M | $62M | $26M | $18M | $55M | $29M | $22M | $15M | $19M | $11M | $9M | |
| Operating Income | $-51M | $-61M | $-25M | $-18M | $-54M | $-30M | $-22M | $-15M | $-19M | $-11M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | $18.0K | |
| Other Non-op | $1M | $462.0K | $394.0K | $-61.0K | $-37.0K | $27.0K | $-3.0K | $91.0K | $-309.0K | $0 | $2.0K | |
| Pretax Income | · | $-61M | $-25M | $-19M | $-53M | $-31M | $-22M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | · | $-9M | $-1M | · | · | · | · | · | |
| Net Income | $-50M | $-61M | $-28M | $-73M | $-64M | $-30M | $-22M | $-16M | $-19M | $-11M | $-9M | |
| EPS (Basic) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | $-0.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | · | · | · | · | · | · | · | |
| Shares (Basic) | 30,476,000 | 13,071,000 | 7,651,000 | 5,540,000 | 88,920 | · | · | · | · | · | · | |
| Shares (Diluted) | 30,476,000 | 13,071,000 | 7,651,000 | 5,540,000 | · | · | · | · | · | · | · | |
| EBITDA | $-49M | $-59M | $-25M | · | · | · | · | · | · | $-11M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $9M | $9M | $20M | $33M | $7M | $22M | $8M | $8M | $10M | $8M | |
| Receivables | $1M | $2M | $484.0K | $2M | $1M | $203.0K | · | · | · | · | · | |
| Inventory | $446.0K | $410.0K | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $821.0K | $643.0K | $977.0K | $901.0K | $1M | $505.0K | $180.0K | $168.0K | $285.0K | $388.0K | |
| Other Current Assets | · | · | · | · | $85.0K | $295.0K | $36.0K | $78.0K | · | $103.0K | $22.0K | |
| Current Assets | $15M | $12M | $11M | $26M | $39M | $9M | $23M | $9M | $9M | $13M | $11M | |
| PP&E (Net) | $6M | $6M | $5M | $9M | $7M | $4M | $4M | $614.0K | $822.0K | $688.0K | $576.0K | |
| PP&E (Gross) | · | · | · | · | $7M | $2M | $1M | $2M | $1M | $1M | $750.0K | |
| Accum. Depreciation | $7M | $8M | $6M | $4M | $3M | $1M | $343.0K | $948.0K | $657.0K | $319.0K | $174.0K | |
| Goodwill | · | · | · | · | $19M | $9M | · | · | · | · | · | |
| Intangibles | $0 | $15M | $57M | $62M | $62M | $15M | · | · | $746.0K | $988.0K | $1M | |
| Other Non-current Assets | $593.0K | $691.0K | $463.0K | $371.0K | $264.0K | $356.0K | $93.0K | · | · | · | · | |
| Total Assets | $26M | $35M | $75M | $100M | $160M | $55M | $40M | $10M | $10M | $14M | $13M | |
| Accounts Payable | $3M | $2M | $953.0K | $1M | $2M | $432.0K | $469.0K | $166.0K | $175.0K | $422.0K | $285.0K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $3M | $3M | · | · | $636.0K | $549.0K | $325.0K | |
| Current Liabilities | $12M | $7M | $7M | $12M | $14M | $9M | $4M | $6M | $4M | $4M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | $187.0K | $289.0K | $310.0K | $0 | |
| Total Liabilities | $57M | $47M | $49M | $60M | $94M | $22M | $9M | $6M | $6M | $5M | $2M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $2M | · | · | |
| Common Stock | $369M | $338M | $310M | $295M | $253M | $157M | $125M | $75M | $60M | $46M | $35M | |
| Retained Earnings | $-401M | $-351M | $-290M | $-261M | $-188M | $-124M | $-94M | $-71M | $-55M | $-35M | $-24M | |
| AOCI | $86.0K | $21.0K | $49.0K | $39.0K | $37.0K | · | · | · | $-888.0K | $-654.0K | $-350.0K | |
| Stockholders' Equity | $-31M | $-12M | $20M | $34M | $65M | $33M | $31M | $3M | $4M | $10M | $10M | |
| Liabilities + Equity | $26M | $35M | $75M | $100M | $160M | $55M | $40M | $10M | $10M | $14M | $13M | |
| Shares Outstanding | 28,683,000 | 17,453,000 | 8,261,000 | 5,932,000 | 92,232,000 | 69,117,000 | 57,032,000 | 40,664,000 | 31,452,000 | 28,737,000 | 25,391,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $800.0K | $313.0K | · | · | · | · | · | |
| Stock-based Comp | $2M | $2M | $3M | $10M | $7M | $5M | $3M | $1M | $2M | · | · | |
| Deferred Tax | · | · | $0 | $0 | $-9M | $-1M | · | · | · | · | · | |
| Amort. of Intangibles | $7.0K | $88.0K | $88.0K | $4M | $3M | $81.0K | · | $121.0K | $242.0K | $242.0K | $242.0K | |
| Other Non-cash | $24M | $37M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-22M | $-21M | $-23M | $-46M | $-36M | $-26M | $-20M | $-12M | $-13M | $-8M | $-4M | |
| CapEx | $3M | $516.0K | $281.0K | $4M | $2M | $1M | $918.0K | $31.0K | $91.0K | $106.0K | $500.0K | |
| Investing Cash Flow | $-3M | $-512.0K | $-932.0K | $-4M | $-14M | $-12M | $-12M | $-31.0K | $843.0K | $-181.0K | $315.0K | |
| Debt Issued | · | · | · | · | · | $1M | · | · | · | · | · | |
| Stock Issued | $29M | $26M | $14M | $33M | $65M | $18M | $49M | $10M | · | $0 | $12M | |
| Net Stock Activity | $29M | $26M | $14M | · | · | · | · | · | · | $0 | · | |
| Financing Cash Flow | $28M | $20M | $12M | $36M | $78M | $23M | $48M | $12M | $10M | $10M | $12M | |
| Net Change in Cash | $3M | $-796.0K | $-12M | $-14M | $28M | $-15M | $16M | $434.0K | $-3M | $2M | $8M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-25M | $-21M | $-24M | · | · | · | · | · | · | $-8M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.7% | 39.3% | 27.5% | · | · | · | · | · | · | · | · | |
| Operating Margin | -1260.8% | -3245.1% | -1672.4% | · | · | · | · | · | · | 39785.7% | · | |
| Net Margin | -1238.5% | -3225.0% | -1848.4% | · | · | · | · | · | · | 39885.7% | · | |
| Pretax Margin | · | -3225.0% | -1653.7% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1206.6% | -3162.0% | -1672.4% | · | · | · | · | · | · | 39785.7% | · | |
| ROA | -165.1% | -110.3% | -31.8% | · | · | · | · | · | · | -82.2% | · | |
| ROE | 330.8% | 4733.8% | -98.2% | · | · | · | · | · | · | -110.1% | · | |
| ROIC | · | 497.3% | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.6 | 1.5 | · | · | · | · | · | · | 3.0 | · | |
| Quick Ratio | 1.1 | 1.4 | 1.4 | · | · | · | · | · | · | 2.4 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | · | · | · | · | · | · | -0.0 | · | |
| Inventory Turnover | 4.1 | 5.1 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 3.0 | 1.8 | 2.8 | · | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.10 | $-0.70 | $2.48 | · | · | · | · | · | · | $0.34 | · | |
| Revenue / Share | $0.13 | $0.14 | $0.20 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.73 | $-1.58 | $-3.05 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.40 | $0.49 | $1.14 | · | · | · | · | · | · | $0.35 | · | |
| EPS (TTM) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | · | · | · | · | · | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 115.6% | 25.1% | 56.9% | -56.4% | 80.8% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 61.8% | -5.1% | 7.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 27.2% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $2M | $2M | $958.0K | $2M | $1M | · | · | · | · | $0 | |
| Net Income TTM | $-50M | $-61M | $-28M | $-73M | $-64M | $-30M | $-22M | $-16M | $-19M | $-11M | $-9M | |
| Market Cap | $215M | $42M | $21M | · | · | · | · | · | · | $4.05B | · | |
| P/E | -4.5 | -0.5 | -0.7 | -0.5 | · | · | · | · | · | · | · | |
| P/S | 53.1 | 22.1 | 13.7 | · | · | · | · | · | · | · | · | |
| P/B | -6.8 | -3.4 | 1.0 | · | · | · | · | · | · | 410.9 | · | |
| P / Tangible Book | · | · | · | · | · | 355.7 | · | · | · | · | · | |
| P / Cash Flow | -9.7 | -2.0 | -0.9 | · | · | · | · | · | · | -538.7 | · | |
| P / FCF | -8.5 | -2.0 | -0.9 | · | · | · | · | · | · | -531.2 | · | |
| Earnings Yield | -22.0% | -195.8% | -150.0% | -206.4% | · | · | · | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239.0K | $32.0K | $1M | $260.0K | $518.0K | $2M | $1M | $115.0K | $104.0K | $176.0K | $314.0K | $429.0K | $463.0K | $297.0K | $274.0K | $67.0K | |
| Cost of Revenue | $82.0K | $17.0K | $655.0K | $121.0K | $180.0K | $813.0K | $869.0K | $43.0K | $32.0K | $109.0K | $409.0K | $159.0K | $169.0K | $265.0K | $278.0K | $314.0K | |
| Gross Profit | $157.0K | $15.0K | $484.0K | $139.0K | $338.0K | $1M | $595.0K | $50.0K | $50.0K | $45.0K | $-117.0K | $248.0K | $272.0K | $10.0K | $-27.0K | $-269.0K | |
| R&D Expense | $4M | $5M | $6M | $4M | $3M | $3M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| SG&A Expense | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $2M | $4M | $3M | $5M | $6M | |
| Operating Expenses | $12M | $4M | $24M | $11M | $10M | $8M | $34M | $14M | $5M | $9M | $16M | $7M | $9M | $-6M | $12M | $1M | |
| Operating Income | $-11M | $-4M | $-23M | $-11M | $-10M | $-7M | $-34M | $-14M | $-5M | $-9M | $-16M | $-7M | $-8M | $6M | $-12M | $-2M | |
| Other Non-op | $162.0K | $146.0K | $506.0K | $223.0K | $125.0K | $157.0K | $146.0K | $53.0K | $110.0K | $153.0K | $269.0K | $127.0K | $-1.0K | $-1.0K | $-365.0K | $62.0K | |
| Pretax Income | · | · | · | · | · | · | · | $-13M | $-5M | $-9M | $-16M | $-6M | $-8M | $6M | $-12M | $-2M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-11M | $-4M | $-23M | $-11M | $-10M | $-7M | $-34M | $-13M | $-5M | $-9M | $-16M | $-6M | $-8M | $3M | $-45M | $-9M | |
| EPS (Basic) | $-0.31 | $-0.12 | $-0.75 | $-0.34 | $-0.30 | $-0.26 | $-2.19 | $-0.98 | $-0.36 | $-1.13 | $-2.27 | $-0.81 | $-1.07 | $0.40 | $-10.04 | $-1.62 | |
| EPS (Diluted) | $-0.31 | $-0.12 | $-0.75 | $-0.34 | $-0.30 | $-0.26 | $-2.19 | $-0.98 | $-0.36 | $-1.13 | $-2.27 | $-0.81 | $-1.07 | $0.40 | $-10.04 | $-1.62 | |
| Shares (Basic) | 36,750,000 | 34,519,000 | · | 32,033,000 | 32,023,000 | 25,694,000 | · | 13,714,000 | 12,870,000 | 8,264,000 | · | 8,256,000 | 8,090,000 | 5,958,000 | · | 5,931 | |
| Shares (Diluted) | 36,750,000 | 34,519,000 | · | 32,033,000 | 32,023,000 | 25,694,000 | · | 13,714,000 | 12,870,000 | 8,264,000 | · | 8,256,000 | 8,090,000 | 5,963,000 | · | 5,931 | |
| EBITDA | $-11M | $-4M | · | $-10M | $-9M | $-6M | · | $-14M | $-5M | $-9M | · | $-7M | $-8M | $6M | · | $-9M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $28M | $12M | $19M | $24M | $31M | $9M | $3M | $9M | $6M | $9M | $14M | $17M | $12M | $20M | $32M | |
| Receivables | $192.0K | $157.0K | $1M | $258.0K | $512.0K | $4M | $2M | $209.0K | $85.0K | $161.0K | $484.0K | $2M | $2M | $2M | $2M | $2M | |
| Inventory | $207.0K | $382.0K | $446.0K | $471.0K | $693.0K | $459.0K | $410.0K | $232.0K | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $1M | $821.0K | $627.0K | $595.0K | $735.0K | $643.0K | $672.0K | $1M | $970.0K | $977.0K | $2M | |
| Current Assets | $21M | $31M | $15M | $21M | $27M | $36M | $12M | $5M | $10M | $7M | $11M | $17M | $21M | $16M | $26M | $37M | |
| PP&E (Net) | $6M | $9M | $9M | $6M | $6M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $7M | $8M | $9M | $9M | |
| Accum. Depreciation | $8M | $10M | $10M | $9M | $8M | $7M | $8M | $7M | $7M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $19M | |
| Intangibles | · | · | $0 | $15M | $15M | $15M | $15M | $57M | $57M | $57M | $57M | $57M | $57M | $57M | $62M | $88M | |
| Other Non-current Assets | $556.0K | $574.0K | $593.0K | $672.0K | $702.0K | $642.0K | $691.0K | $699.0K | $563.0K | $438.0K | $463.0K | $520.0K | $329.0K | $367.0K | $371.0K | $366.0K | |
| Total Assets | $29M | $40M | $26M | $44M | $51M | $60M | $35M | $70M | $75M | $71M | $75M | $82M | $88M | $83M | $100M | $157M | |
| Accounts Payable | $2M | $2M | $3M | $1M | $1M | $2M | $2M | $872.0K | $1M | $908.0K | $953.0K | $1M | $875.0K | $1M | $1M | $2M | |
| Accrued Liabilities | $2M | $3M | $2M | $2M | $1M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $4M | |
| Current Liabilities | $10M | $12M | $12M | $8M | $7M | $10M | $7M | $9M | $7M | $8M | $7M | $8M | $8M | $9M | $12M | $13M | |
| Total Liabilities | $51M | $51M | $57M | $53M | $49M | $50M | $47M | $61M | $52M | $54M | $49M | $39M | $39M | $39M | $60M | $75M | |
| Common Stock | $395M | $394M | $369M | $369M | $368M | $367M | $338M | $327M | $326M | $311M | $310M | $310M | $310M | $296M | $295M | $293M | |
| Retained Earnings | $-416M | $-405M | $-401M | $-378M | $-367M | $-357M | $-351M | $-317M | $-304M | $-299M | $-290M | $-272M | $-266M | $-258M | $-261M | $-216M | |
| AOCI | $67.0K | $71.0K | $86.0K | $86.0K | $85.0K | $41.0K | $21.0K | $57.0K | $37.0K | $40.0K | $49.0K | $32.0K | $41.0K | $43.0K | $39.0K | $19.0K | |
| Stockholders' Equity | $-21M | $-11M | $-31M | $-9M | $1M | $10M | $-12M | $10M | $23M | $12M | $20M | $38M | $44M | $38M | $34M | $77M | |
| Liabilities + Equity | $29M | $40M | $26M | $44M | $51M | $60M | $35M | $70M | $75M | $71M | $75M | $82M | $88M | $83M | $100M | $157M | |
| Shares Outstanding | 32,623,000 | 32,286,000 | 28,683,000 | 28,625,000 | 28,617,000 | 28,599,000 | 17,453,000 | 13,374,000 | 13,368,000 | 8,273,000 | 8,261,000 | 8,261,000 | 8,241,000 | 119,279,000 | 5,932,000 | 118,619,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $665.0K | $631.0K | $563.0K | $584.0K | $559.0K | $491.0K | $563.0K | $340.0K | $326.0K | $335.0K | $303.0K | $404.0K | $435.0K | $450.0K | $466.0K | $391.0K | |
| Stock-based Comp | $661.0K | $615.0K | $721.0K | $521.0K | $504.0K | $473.0K | $499.0K | $450.0K | $386.0K | $418.0K | $484.0K | $608.0K | $834.0K | $834.0K | $3M | $3M | |
| Amort. of Intangibles | $0 | $0 | $0 | $0 | $0 | $7.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $812.0K | $976.0K | |
| Other Non-cash | · | $-5M | · | · | · | $-151.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-6M | $-5M | $-6M | $-6M | $-5M | $-6M | $-6M | $-4M | $-4M | $-2M | $-5M | $-8M | $-10M | $-11M | |
| CapEx | $779.0K | $613.0K | $1M | $1M | $349.0K | $307.0K | $214.0K | $87.0K | $191.0K | $24.0K | $264.0K | · | · | · | $802.0K | $859.0K | |
| Investing Cash Flow | $-779.0K | $-613.0K | $-1M | $-1M | $-349.0K | $-307.0K | $-210.0K | $-87.0K | $-191.0K | $-24.0K | $103.0K | $-1M | $123.0K | $-1M | $-802.0K | $-859.0K | |
| Stock Issued | $0 | $26M | $0 | $0 | $0 | $29M | $10M | $0 | $16M | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | $26M | · | · | · | $29M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-564.0K | $25M | $-252.0K | $-120.0K | $-114.0K | $29M | $11M | $-255.0K | $10M | $0 | $-30.0K | $-30.0K | $12M | $-28.0K | $-100.0K | $-572.0K | |
| Net Change in Cash | $-11M | $16M | $-7M | $-6M | $-7M | $22M | $5M | $-6M | $4M | $-4M | $-4M | $-4M | $6M | $-10M | $-11M | $-13M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-8M | · | · | · | $-6M | · | · | · | $-4M | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.7% | 46.9% | · | 53.5% | 67.6% | 62.0% | · | 43.5% | 48.1% | -55.7% | · | 57.8% | 58.8% | 3.4% | · | -115.4% | |
| Operating Margin | -4770.7% | -13790.6% | · | -4249.2% | -1900.0% | -318.0% | · | -11752.2% | -4453.9% | -5265.3% | · | -1518.2% | -1791.4% | 1952.2% | · | -906.7% | |
| Net Margin | -4711.3% | -13406.2% | · | -4174.6% | -1880.7% | -312.0% | · | -11733.0% | -4355.8% | -5186.9% | · | -1512.6% | -1799.8% | 1021.2% | · | -917.7% | |
| Pretax Margin | · | · | · | · | · | · | · | -11733.0% | -4355.8% | -5186.9% | · | -1512.6% | -1799.8% | 2006.4% | · | -917.7% | |
| EBITDA Margin | -4492.5% | -11818.8% | · | -4024.6% | -1792.1% | -295.0% | · | -11752.2% | -4453.9% | -5265.3% | · | -1518.2% | -1791.4% | 1952.2% | · | -906.7% | |
| ROA | -28.2% | -8.5% | · | -19.0% | -15.6% | -10.2% | · | -17.8% | -5.6% | -11.9% | · | -5.4% | -6.4% | 2.6% | · | -5.7% | |
| ROE | 111.5% | 1814.0% | · | -4215.1% | -81.9% | -61.2% | · | -57.1% | -13.7% | -36.9% | · | -11.3% | -13.1% | 6.4% | · | -10.6% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.5 | · | 2.8 | 4.0 | 3.7 | · | 0.5 | 1.4 | 0.8 | · | 2.1 | 2.7 | 1.7 | · | 2.8 | |
| Quick Ratio | 1.7 | 2.4 | · | 2.5 | 3.7 | 3.6 | · | 0.4 | 1.3 | 0.7 | · | 2.0 | 2.5 | 1.5 | · | 2.6 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.2 | 0.0 | · | 0.3 | 0.5 | 3.5 | · | 0.4 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.7 | 0.0 | · | 1.1 | 1.7 | 1.2 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.3 | 0.1 | · | 0.7 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.65 | $-0.33 | · | $-0.32 | $0.04 | $0.36 | · | $0.73 | $1.70 | $1.40 | · | $4.55 | $5.29 | $0.32 | · | $0.65 | |
| Revenue / Share | $0.01 | $0.00 | · | $0.01 | $0.02 | $0.08 | · | $0.01 | $0.01 | $0.02 | · | $51.96 | $57.23 | $0.00 | · | · | |
| Cash Flow / Share | · | $-0.22 | · | · | · | $-0.23 | · | · | · | $-0.46 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.54 | $0.87 | · | $0.65 | $0.85 | $1.08 | · | $0.25 | $0.69 | $0.67 | · | $1.67 | $2.11 | $0.10 | · | $0.27 | |
| EPS (TTM) | $-1.52 | $-1.51 | · | $-3.09 | $-3.73 | $-3.79 | · | $-4.74 | $-4.57 | $-5.28 | · | $-11.52 | $-12.33 | $-12.74 | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $4M | $4M | $4M | · | $709.0K | $1M | $1M | · | $1M | $1M | $875.0K | · | $-1M | |
| Net Income TTM | $-49M | $-48M | · | $-61M | $-63M | $-58M | · | $-43M | $-36M | $-40M | · | $-57M | $-60M | $-60M | · | $-64M | |
| Market Cap | $192M | $106M | · | $95M | $86M | $88M | · | $38M | $39M | $24M | · | $26M | $38M | $844M | · | $1.73B | |
| P/E | -3.9 | -2.2 | · | -1.1 | -0.8 | -0.8 | · | -0.6 | -0.6 | -0.6 | · | -0.3 | -0.4 | -0.6 | · | · | |
| P/S | 115.3 | 54.3 | · | 21.6 | 20.3 | 22.8 | · | 53.8 | 38.5 | 17.5 | · | 17.6 | 34.4 | 965.1 | · | -1378.9 | |
| P/B | -9.0 | -9.9 | · | -10.3 | 78.7 | 8.6 | · | 3.9 | 1.7 | 2.1 | · | 0.7 | 0.9 | 22.3 | · | 22.5 | |
| P / Cash Flow | · | -13.9 | · | · | · | -14.9 | · | · | · | -6.3 | · | · | · | -87.3 | · | · | |
| Earnings Yield | -25.8% | -46.0% | · | -93.1% | -123.5% | -123.9% | · | -166.3% | -154.9% | -180.2% | · | -369.2% | -268.0% | -179.9% | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $4M | $2M | $2M | $958.0K | $2M |
| Margen Bruto % | 56.7% | 39.3% | 27.5% | · | · |
| Margen Operativo % | -1260.8% | -3245.1% | -1672.4% | · | · |
| Beneficio neto | $-50M | $-61M | $-28M | $-73M | $-64M |
| EPS Diluido | $-1.65 | $-4.66 | $-3.75 | $-13.25 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 1.3 | 1.6 | 1.5 | · | · |
| Ratio Rápido | 1.1 | 1.4 | 1.4 | · | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-25M | $-21M | $-24M | · | · |
Propietarios institucionales (13F) 43 declarantes · $111.8M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
43
Valor en tenencia
$111.8M
Nuevas posiciones
11
Posiciones cerradas
13
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 11 (-6 vs trimestre anterior) | 13 (+6 vs trimestre anterior) | 10 (-1 vs trimestre anterior) | 8 (+2 vs trimestre anterior) | -474K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BROADWOOD CAPITAL INC | $74 840 816 | 12 684 884 | 66,93% | Acciones |
| AWM Investment Company, Inc. | $16 736 483 | 2 836 692 | 14,97% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $4 341 497 | 735 847 | 3,88% | Acciones |
| VANGUARD GROUP INC | $3 950 064 | 526 675 | 3,53% | Acciones |
| PURA VIDA INVESTMENTS, LLC | $2 860 585 | 484 845 | 2,56% | Acciones |
| Family Office Research LLC | $2 176 207 | 368 849 | 1,95% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $1 516 953 | 256 903 | 1,36% | Acciones |
| JANE STREET GROUP, LLC | $930 324 | 157 682 | 0,83% | Acciones |
| BlackRock, Inc. | $888 074 | 150 521 | 0,79% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $734 998 | 124 576 | 0,66% | Acciones |
| STATE STREET CORP | $543 532 | 92 124 | 0,49% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $486 744 | 82 499 | 0,44% | Acciones |
| UBS Group AG | $314 329 | 53 276 | 0,28% | Acciones |
| NORTHERN TRUST CORP | $289 631 | 49 090 | 0,26% | Acciones |
| OSAIC HOLDINGS, INC. | $230 901 | 39 136 | 0,21% | Acciones |
| MORGAN STANLEY | $209 539 | 35 515 | 0,19% | Acciones |
| Jefferies Financial Group Inc. | $106 790 | 18 100 | 0,10% | Acciones |
| MARSHALL WACE, LLP | $97 922 | 16 597 | 0,09% | Acciones |
| ExodusPoint Capital Management, LP | $82 771 | 14 029 | 0,07% | Acciones |
| AXQ CAPITAL, LP | $79 101 | 13 407 | 0,07% | Acciones |
| Flatrock Wealth Partners LLC | $76 960 | 13 044 | 0,07% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $65 496 | 11 101 | 0,06% | Acciones |
| XTX Topco Ltd | $63 384 | 10 743 | 0,06% | Acciones |
| Private Advisor Group, LLC | $61 454 | 10 416 | 0,05% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $34 226 | 5 801 | 0,03% | Acciones |
| Vanguard Global Advisers, LLC | $34 073 | 5 775 | 0,03% | Acciones |
| EverSource Wealth Advisors, LLC | $29 500 | 5 000 | 0,03% | Acciones |
| Tower Research Capital LLC (TRC) | $15 877 | 2 691 | 0,01% | Acciones |
| Steward Partners Investment Advisory, LLC | $11 564 | 1 960 | 0,01% | Acciones |
| ORG Partners LLC | $3 375 | 450 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $1 092 | 185 | 0,00% | Acciones |
| FNY Investment Advisers, LLC | $1 077 | 182 561 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $1 000 | 251 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $835 | 154 | 0,00% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $340 | 63 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $266 | 45 | 0,00% | Acciones |
| Piscataqua Savings Bank | $147 | 25 | 0,00% | Acciones |
| ALBION FINANCIAL GROUP /UT | $42 | 7 | 0,00% | Acciones |
| WELLS FARGO & COMPANY/MN | $41 | 7 | 0,00% | Acciones |
| Cassaday & Co Wealth Management LLC | $36 | 6 | 0,00% | Acciones |
| Global Retirement Partners, LLC | $6 | 1 | 0,00% | Acciones |
| Farther Finance Advisors, LLC | $6 | 1 | 0,00% | Acciones |
| Motiv8 Investments LLC | $0 | 10 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher ×15 presentaciones | 27 de abril de 2026 | 39,70% | Enmienda | Inversión pasiva | SEC |
| Lineage Cell Therapeutics, Inc. 1 S.S. OR ×4 presentaciones | 8 de enero de 2021 | · | Presentación inicial | · | SEC |
| BioTime, Inc. 1 S.S. OR ×5 presentaciones | 5 de julio de 2019 | · | Presentación inicial | · | SEC |
| BioTime, Inc. S.S. OR | 29 de agosto de 2016 | · | Presentación inicial | Campaña de la junta directiva | SEC |
| BioTime, Inc. | 31 de diciembre de 2015 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 29 insiders · 16 directivos · 13 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Josh Riggs | CEO and President | 26 de marzo de 2026 M | 38 365 | 0 | 0 | $0 |
| Ronald Asbury Andrews | Former CEO | 7 de diciembre de 2022 A | 583 212 | 0 | 0 | $0 |
| William Annett | President and CEO | 14 de marzo de 2019 A | 3 500 | 0 | 0 | $0 |
| Andrea S. James | Chief Financial Officer | 26 de marzo de 2026 M | 206 060 | 0 | 0 | $0 |
| Anish M. John | Chief Financial Officer | 24 de febrero de 2023 A | 150 000 | 0 | 0 | $0 |
| Mitchell S Levine | Chief Financial Officer | 15 de marzo de 2022 A | 87 080 | 0 | 0 | $0 |
| Gisela Paulsen | Former President and COO | 16 de diciembre de 2022 D | 366 500 | 0 | 0 | $0 |
| Albert P Parker | COO | 11 de diciembre de 2020 A | 10 586 | 0 | 0 | $0 |
| James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | 26 de marzo de 2026 M | 3 711 | 0 | 0 | $0 |
| Douglas T. Ross | Former CSO | 21 de diciembre de 2022 A | 234 114 | 0 | 0 | $0 |
| Li Yu | VP Cntrllr/Prncpl Acctng Offcr | 18 de mayo de 2022 M | 16 872 | 0 | 0 | $0 |
| Padma Sundar | Chief Commercial Officer | 15 de marzo de 2022 A | 4 177 | 0 | 0 | $0 |
| Lyndal K. Hesterberg | CSO | 11 de diciembre de 2020 A | 7 477 | 0 | 0 | $0 |
| Tony T Kalajian | Sr.VP/Chief Accounting Officer | 3 de agosto de 2020 P | 15 000 | 0 | 0 | $0 |
| Kristine C. Mechem | VP of Marketing | 7 de junio de 2018 A | · | 0 | 0 | $0 |
| Karen B. Chapman | Vice President of Research | 16 de febrero de 2016 A | · | 0 | 0 | $0 |
| Andrew J. Last | Consejero | 1 de julio de 2026 F | 58 752 | 0 | 0 | $0 |
| Andrew Arno | Consejero | 1 de julio de 2026 F | 156 785 | 0 | 0 | $0 |
| Lou Silverman | Consejero | 1 de julio de 2026 F | 55 807 | 0 | 0 | $0 |
| Alfred D Kingsley | Consejero | 23 de junio de 2023 A | 489 111 | 0 | 0 | $0 |
| Jennifer L. Carter | Consejero | 15 de agosto de 2022 A | 30 500 | 0 | 0 | $0 |
| Melinda Griffith | Consejero | 15 de agosto de 2022 A | 30 000 | 0 | 0 | $0 |
| Cavan M. Redmond | Consejero | 24 de junio de 2022 M | 120 863 | 0 | 0 | $0 |
| Aditya P. Mohanty | Consejero | 17 de julio de 2019 A | · | 0 | 0 | $0 |
| Don M Bailey | Consejero | 15 de junio de 2017 A | · | 0 | 0 | $0 |
| Michael D West | Consejero | 16 de febrero de 2016 A | · | 0 | 0 | $0 |
| Patrick W Smith | Propietario del 10% | 7 de febrero de 2025 J | 3 258 485 | 0 | 0 | $0 |
| John Peter Gutfreund | · | 30 de junio de 2023 J | 0 | 0 | 0 | $0 |
| BIOTIME INC | · | 2 de enero de 2020 S | 6 041 154 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 3 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
IMDX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 11 analistas
COMPRA
Objetivo mediano
$8.50
+147,1%
2 18,2%
Compra fuerte
6 54,5%
Compra
3 27,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
4 analistas · 2026-09-29Objetivo medio $8.25 +139,8%
← Por Debajo de Todos los Objetivos
Precio Actual $3.44
Mín$4.00
Media$8.25
Máx$12.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
| HURA | · | -1.2 | · | · | · | · |
| VTVT | · | · | · | · | -70.4% | · |
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
| UNCY | $128M | -3.5 | -29.0% | · | -113.9% | · |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | · |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| BDTX | $139M | 6.2 | · | 31.9% | 18.3% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 10, 2026